|Bid||0.008 x 261000000|
|Ask||0.009 x 24000000|
|Day's range||0.008 - 0.009|
|52-week range||0.006 - 0.021|
|PE ratio (TTM)||N/A|
|Earnings date||1 Mar. 2016 - 5 Mar. 2016|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.25|
Launched a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month BREVAGen plus commercial program to transition to an ecommerce based solution Ohio State University ...
ASX ANNOUNCEMENT 23 November, 2016 Results from 2016 Annual General Meeting Melbourne, Australia; 23 November 2016: Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, "Company") advises that ...